Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease.
about
Role of diet on non-alcoholic fatty liver disease: An updated narrative reviewSerum Alanine Aminotransferase Trends and Their Relationship with Obesity and Metabolic Syndrome in United States Adolescents, 1999-2014.The cirrhosis epidemic in the UK: evaluating the causes in a European context.Evaluation of carotid artery stiffness in obese children using ultrasound radiofrequency data technology.Nonalcoholic Fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic "mal-programming".Association of the components of the metabolic syndrome with non-alcoholic fatty liver disease among normal-weight, overweight and obese children and adolescents.Fatty liver disease in children: eat now pay later.Natural History of NAFLD Diagnosed in Childhood: A Single-Center Study.The effects of vitamin D supplementation on hepatic dysfunction, vitamin D status, and glycemic control in children and adolescents with vitamin D deficiency and either type 1 or type 2 diabetes mellitusSAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver diseasePediatric Non-Alcoholic Fatty Liver DiseaseMetabolic syndrome, insulin resistance and Fatty liver in obese Iranian childrenSteatosis and steatohepatitis: complex disorders.Nonalcoholic fatty liver disease as a comorbidity of childhood obesity.Predicting hepatic steatosis in a racially and ethnically diverse cohort of adolescent girls.Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver diseaseTreatment of nonalcoholic fatty liver disease in children: TONIC trial design.The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy.Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver diseasePediatric nonalcoholic fatty liver disease: A clinical and laboratory challengeReview article: the management of paediatric nonalcoholic fatty liver disease.Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children?The metabolic syndrome and nonalcoholic fatty liver disease in childrenOverweight and obesity in children and adolescentsMedical and psychosocial implications of adolescent extreme obesity - acceptance and effects of structured care, short: Youth with Extreme Obesity Study (YES).Protective effect of whey proteins against nonalcoholic fatty liver in rats.Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.Serum alanine aminotransferase and its association with metabolic syndrome in children: the bogalusa heart study.Physical activity and nutrition attitudes in obese Hispanic children with non-alcoholic steatohepatitis.The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.Overview of screening methods for fatty liver disease in children.A clinically relevant method to screen for hepatic steatosis in overweight adolescents: a cross sectional study.Choline intake in a large cohort of patients with nonalcoholic fatty liver disease.Pediatric obesity. An introductionProton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women.Non-alcoholic fatty liver disease is associated with low bone mineral density in obese childrenFeasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease.Risk Score Model for Predicting Sonographic Non-alcoholic Fatty Liver Disease in Children and Adolescents.Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004.Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome.
P2860
Q27000333-B86A2A32-8F8E-44E1-A8D4-A819393E8771Q30252383-7D070F7E-6757-4B29-81B8-35A743B2CC80Q30373848-E822967C-0550-49D2-9749-7D4CDD75289CQ30583357-CE9E5D13-965B-492C-9ACC-7F98B3FE4144Q33580031-D3FFEF2F-9F7C-4552-8D12-C9BB2CB6E22BQ33587123-7DCE9095-3F88-4707-B1C3-8AD37A3039CBQ33718945-3837CCEB-6788-43F5-8386-16CC80634A71Q33737389-3A03882D-B2D9-48D9-A9C3-3DB811A5EEC6Q33740329-7C246D50-AB47-42E9-9E58-EA889B6CCC47Q33759095-49251936-863E-4FFD-AFB0-3B3150A7837CQ33831717-C1287C23-AE7E-4987-A3F4-4DB19DD04087Q33848396-352C8E81-724A-4F0F-B355-8741251D3899Q33907632-3425936D-294F-4552-893B-CA5C2AFBE5CEQ33913788-098893B4-30DB-4CBD-B8B9-1147C9F8F659Q34040931-3E81A1F0-28A0-4BD8-B3D8-7B513CF1DF29Q34069352-CE87DC36-66FC-42A0-8CDC-EFB4FE0A8079Q34114795-EAFB5061-EE85-47A7-8645-1C9B9AF9E9D3Q34153340-9D2CA63D-B04D-4A8C-9A0C-E53A6C8DD238Q34378263-DC8D30DA-2FC2-410B-8935-37112EFCA736Q34390296-9BBD636C-8342-46E0-9B24-49E7A14C91F8Q34440962-F0620E95-B7E6-49E3-9A65-E4A2D5235694Q34591166-60F277E8-B473-4177-9ED1-27D3719B28BEQ34778237-C5A318F2-3C93-417E-BC6F-1109066F5AF6Q34948884-D11F08A6-24C2-4BA5-93A3-DC7B4FFCE3C1Q34976145-6D704F48-8C81-4E22-A61A-1D243EFB60B4Q34987437-A1AD34F5-3EB1-493B-AB7F-36FCC75EEF4AQ35031127-0D94D8E6-E363-472B-BC35-A9D0AB182033Q35075074-AC55883B-C7E2-437D-BA84-52CFCB5B561DQ35555722-21289BC9-AD3D-4C24-A834-A2311CA74F16Q35733564-F0B6239B-B3F5-4F39-B289-BA0A3932E6E3Q35736511-AE4B8F68-B729-477F-A0CD-3C14D922BA4EQ35801157-49B3E7E0-7EDD-43CA-A3D9-F93E29E8B315Q35826420-53492E5C-EF1A-4C72-898E-033848A49618Q35988582-AAB05F5E-AB0B-438C-A6A0-7832F5FA6982Q36042485-51AFAC4E-4260-4806-9D89-CB3CA28E15AFQ36219486-673A90C5-9E72-4FF9-8D8E-837FB8128CEDQ36240453-61925A6D-8096-4166-BFD2-1362B608F818Q36244818-5AC82FBC-FBEF-465C-ACF8-87A3F9C61474Q36334302-754A0295-871B-4652-9414-BE6561167C1CQ36531438-5DC63492-3123-491A-A360-2A3E9CB962F2
P2860
Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Obesity, insulin resistance, a ...... alcoholic fatty liver disease.
@ast
Obesity, insulin resistance, a ...... alcoholic fatty liver disease.
@en
type
label
Obesity, insulin resistance, a ...... alcoholic fatty liver disease.
@ast
Obesity, insulin resistance, a ...... alcoholic fatty liver disease.
@en
prefLabel
Obesity, insulin resistance, a ...... alcoholic fatty liver disease.
@ast
Obesity, insulin resistance, a ...... alcoholic fatty liver disease.
@en
P2093
P1476
Obesity, insulin resistance, a ...... alcoholic fatty liver disease.
@en
P2093
Cynthia Behling
Jeffrey B Rauch
Joel E Lavine
Reena Deutsch
Robert Newbury
P304
P356
10.1067/S0022-3476(03)00325-1
P407
P577
2003-10-01T00:00:00Z